Beijing Beilu Pharmaceutical Co. Ltd. | Ownership
Companies that own Beijing Beilu Pharmaceutical Co. Ltd.
Xingzheng Securities Asset Management Ltd.
4,478,716
1.18%
4,478,716
0.91%
03/31/2017
China Universal Asset Management Co., Ltd.
3,095,547
0.81%
-14,899,450
0.05%
03/31/2017
Chongqing International Trust Co., Ltd.
1,390,000
0.37%
1,390,000
0.42%
03/31/2017
E Fund Management Co., Ltd.
1,343,118
0.35%
1,156,266
0.02%
03/31/2017
Guotai Asset Management Co., Ltd.
618,885
0.16%
618,885
0.02%
12/31/2017
Huashang Fund Management Co., Ltd.
271,000
0.07%
271,000
0.02%
12/31/2017
GF Fund Management Co., Ltd.
138,450
0.04%
18,500
0%
12/31/2017
First-Trust Fund Management Co., Ltd.
30,000
0.01%
0
0.03%
12/31/2017
China Southern Asset Management Co., Ltd.
5,500
0%
-58,100
0%
12/31/2017
Hwabao WP Fund Management Co., Ltd.
3,600
0%
-700
0%
12/31/2017
| Address |
7/F, Blk A, Fenglan Intl Office Bldg
Beijing Beijing 100082
China
|
|
Employees
|
- |
| Website |
http://www.beilu.com.cn |
| Updated |
07/08/2019 |
| Beijing Beilu Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical product. Its products cover contrast medium product, glimepiride, and anti-anxiety product. The contrast medium product includes ferric ammonium citrate, gadopentetate, and iohexol injection. |
